CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- 4 Exercise or conversion SVP, CFO and Secretary acquired 6,516 shares (option exercise)
- 4 Open-market sale Sr VP, Clinical Dev. & CMO sold 5,000 shares at $20.00 ($100,000)
- 4 Exercise or conversion Sr VP & Chief Business Officer acquired 2,000 shares (option exercise)
- 4 Exercise or conversion SVP, CFO and Secretary acquired 3,000 shares (option exercise)
- 4 Open-market sale Sr VP, Clinical Dev. & CMO sold 5,000 shares at $20.00 ($100,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Sr VP, Clinical Dev. & CMO sold 10,000 shares at $20.00 ($200,000)
- 4 Exercise or conversion SVP, CFO and Secretary acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Sr VP & Chief Business Officer acquired 2,000 shares (option exercise)
- 4 Exercise or conversion Sr VP, Research & CSO acquired 53,264 shares (option exercise)
- 4 Open-market sale Sr VP, Clinical Dev. & CMO sold 5,000 shares at $20.00 ($100,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 25 · 484 filings